AI & Analytics Consumption: Insights on Demand

Posted by Arun Shastri on Wed, Oct 02, 2019

This blog post is the fifth in a series on the impact that AI will have on different business aspects of pharma.

The past few years have seen an explosion of data, and with it, the need to make use of it. Gathering and stitching together internal and external data sources presents one set of challenges, but what about the analysts who struggle to leverage all of this data? How can they keep up with increasing demands for data-driven insights from the entire organization? How can we empower the whole organization to have access to these critical insights? Here’s a hint: AI is part of the solution.


>
Read More

Boost Patient Recruitment With Data-Centric Trial Planning

Posted by Venkat Sethuraman on Fri, Aug 16, 2019

Denise N. Bronner, Gaurav A. Singh and Ray Zhong co-wrote this blog post with Venkat Sethuraman

A common struggle for pharmaceutical companies is poor patient recruitment for clinical trials. As a consequence, 80% of clinical trials fail to meet their enrollment goals, suffer delayed timelines and absorb skyrocketing R&D costs. Ultimately, the patient suffers from delays in the release of needed therapies. Currently, pharmaceutical companies are partnering with trial matching startups to enhance clinical study design, matching and data collection. With analytics and platforms, pharmaceutical companies are beginning to streamline the clinical trial process in hopes of increasing new entrants to the market.


>
Read More

A Panel of Experts Talk MDM in Healthcare: Three Takeaways

Posted by Ankit Jain on Mon, Jun 10, 2019

The potential of digital transformation is being realized across industries. In healthcare, advanced analytics has streamlined processes, sped up research and promises to drive better health outcomes. But advanced analytics are nothing without data, and unless you can break down data siloes across the enterprise and merge critical data into a single source of truth (otherwise known as master data management, or MDM), then your data will be insufficient to drive this kind of transformation.

I recently participated in a panel discussion for Informatica World 2019 with representatives from Intermountain Health and The American Cancer Society. We discussed MDM’s role in healthcare as a driver of digital transformation.

After reflecting on the conversation, I took three things away from the event:


>
Read More

How to Get Pharma Leaders to Wrap Their Minds—and Their Arms—Around Advanced Analytics

Posted by Shreyas Murthi on Mon, Mar 11, 2019

 

The business of pharma is becoming more data-driven—from R&D to commercial—yet many pharma companies still struggle to garner leaders’ buy-in to build and operate the analytics programs that they need to fuel their success. They face tough challenges, including overcoming skepticism, proving the program’s value and scalability, finding the right talent and ensuring organizational collaboration.    


>
Read More

Making the Case for a New Analytics Consumption Model

Posted by ZS Editors on Thu, Nov 29, 2018

Industries like retail and technology are transitioning to an AI-driven, personalized approach to surfacing insights to end users, and they’re reaping the benefits. Life sciences companies have the same opportunity to capitalize on the runaway growth in data and rethink the way that analytics are consumed.  

ZS recently partnered with IDC to study how commercial life sciences teams are currently consuming data, and to determine their data and analytics pain points. The study revealed that sales and marketing professionals in life sciences want


>
Read More